You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
These past years, the media have focused public attention on malpractice in the field of organ donation, with the risk of forgetting that organ donation provides an extraordinary hope of saving lives and gives a splendid example of human solidarity. Transplantation was made possible by the development of scientific and medical knowledge together with the dedication of skilled teams throughout Europe. The shortage of organs and tissue is the key factor for all the problems within the system: the size of the European Union will help to deal with this reality and requires the cooperation of medical teams, dispatching organisms and public health authorities at the European level. The transparency of a faultless organization, from the technical and ethical points of view will increase the public's support of organ donation and decrease organ shortage. The development of the European Union, resulting in free movement within the international market, makes harmonisation of the donation system unavoidable. From the Introduction by Magda de Galan, Belgian Minister of Health.
This concise and practical book is the first of its kind to examine the use of assisted reproductive technologies (ART) in relation to blood-borne infectious diseases: human immunodeficiency virus (HIV), hepatitis B (HBV) and hepatitis C (HCV). The book opens with a discussion of the impact of these viruses on male and female fertility, followed by specific chapters of each of them, including ART with HIV and HCV serodiscordant couples (where either the male or female is positive) and the detection and impact of HBV and HCV in human gametes and embryos. An important character on laboratory safety when performing ART with blood-borne viruses follows, and the book concludes with a discussion of ART in austere and resource-poor settings, where these infections are often dominant due to lack of treatment and access to vaccines. Written and edited by an international array of experts in reproductive medicine, Assisted Reproductive Technologies and Infectious Diseases explores questions, techniques, and related issues with the aim of effectively helping clinicians working with serodiscordant couples wishing to have children.
This is the 1st edition of the book A Workbook on Human Spermatozoa and Assisted Conception. The text is comprehensive, updated and fully revised as per the present day requirements in the subject of assisted conception. The book has 17 chapters classified into twelve sections. The first chapter deals with equipments and culture media used in semen analysis. Subsequent two chapters are computer assisted semen analysis which provides a comprehensive description of human semen analysis with the help of well-illustrated diagrams in a user friendly language. A sound foundation of understanding of sperm morphology and semen preparation is provided in the next three chapters giving details of semen ejaculate, semen extract and semen preparation of infected semen sample in simple text and easy to understand illustrations along with recent advances. Oxidative stress test is described in chapter 10. The chapter 11 to 14 deal with different tests done on sperms. Chapter fifteen describes Oocyte spindle imaging system. The chapter 16th and 17th deal with semen banking and vitrification. A comprehensive index is given at last.
In most Council of Europe member states, active euthanasia or assisting a suicide are illegal. The issue is the subject of a lively debate, both in professional circles and amongst the general public, and two countries, the Netherlands and Belgium, have decided to change their laws to enable doctors to bring a person's life to an end if certain conditions are fulfilled. This publication takes a detailed look at the practical and legal situation in eight European countries and the United States, as well as taking stock of the discussions taking place throughout Europe on various aspects of the end of life. The ethical and human aspects of the euthanasia debate are discussed in another publication (ISBN 9287150702).
By providing an interdisciplinary reading of advance directives regulation in international, European and domestic law, this book offers new insights into the most controversial legal issues surrounding the debate over dignity and autonomy at the end of life.
In this important new book Gregory E. Pence looks at issues on the frontiers of medicine including gene therapy to produce 'brave new babies', cloning, human eggs and embryos for sale and experiments on human embryos. Pence argues that the conservatism of the medical establishment, the bioethics community, and the public at large has created shibboleths that impede improvements in our quality of life.
This comprehensive overview of the known literature concerning the physical and psychosocial health of children conceived by ART brings together an international panel of experts in fertility medicine, epidemiology, medical genetics, obstetrics, twin research, psychosocial development and pediatrics. Each chapter gives a concise, readable commentar
This book is focused on the protection of female reproductive health. Artificial pregnancy termination is known to be associated with an increased risk of infertility, spontaneous pregnancy loss, and other gestational pathologies. Since family planning is a system for the prevention of unwanted pregnancy, the current situation of the spread of induced abortion in different parts of the world is analyzed. Early pregnancy loss is a wide-ranging problem in medicine and habitual abortion is a real tragedy for women in their childbearing years. The different pathogenetic scenarios of spontaneous pregnancy termination are described and the possible interventions for prevention contributing to beneficial outcomes are discussed.
In line with its strong position in clinical research, Belgium is one of the first European Member States where the implementing regulation of the Clinical Trials Directive is fully operational. The specific conditions provided for in the new law concerning experiments on the human person (May 7, 2004) reinforce Belgium as a very attractive host for clinical trials, ensuring a lasting environment for innovative research. pharma.be, the Belgian Pharmaceutical Industry Association, wants to contribute its part to research in Belgium by clarifying the practical implications of the new regulations. At its request, dr. iur. Caroline Trouet wrote an Operational Guidance, which analyses the new Bel...